Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
ASO Visual Abstract: Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma-Results from the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy.
Journal: Annals of surgical oncology
Published: June 17, 2026
Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy.
Journal: Annals of surgical oncology
Published: February 24, 2026
Multiplex immunofluorescence in the identification of immune cell compositions in rejection, bronchus-associated lymphoid tissue, and infection in lung allograft tissue.
Journal: Virchows Archiv : an international journal of pathology
Published: November 24, 2025
Accuracy of PET-CT to Assess the Extent of Nodal Disease in Patients with Clinical Stage III Melanoma Following Neoadjuvant Treatment.
Journal: Annals of surgical oncology
Published: June 19, 2025
NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 10, 2025
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trial.
Journal: Journal for immunotherapy of cancer
Published: April 01, 2025
Democratizing Artificial Intelligence in Anatomic Pathology.
Journal: Archives of pathology & laboratory medicine
Published: February 14, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial.
Journal: Nature communications
Published: October 03, 2023
Using an anomaly detection approach for the segmentation of colorectal cancer tumors in whole slide images.
Journal: Journal of pathology informatics
Published: July 17, 2023
Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy.
Journal: Gastro hep advances
Published: June 02, 2023
Resolving the heterogeneous tumor-centric cellular neighborhood through multiplexed, spatial paracrine interactions in the setting of immune checkpoint blockade.
Journal: Cancer research communications
Published: August 22, 2022
Last Updated: 09/26/2026